Cargando…
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
Enhanced DNA damage repair is one mechanism involved in colon cancer drug resistance. Thus, targeting molecular components of repair pathways with specific small molecule inhibitors may improve the efficacy of chemotherapy. ABT-888 and VE-821, inhibitors of poly-ADP-ribose-polymerase (PARP) and the...
Autores principales: | Abu-Sanad, Atlal, Wang, Yunzhe, Hasheminasab, Fatemeh, Panasci, Justin, Noë, Alycia, Rosca, Lorena, Davidson, David, Amrein, Lilian, Sharif-Askari, Bahram, Aloyz, Raquel, Panasci, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510998/ https://www.ncbi.nlm.nih.gov/pubmed/26257651 http://dx.doi.org/10.3389/fphar.2015.00147 |
Ejemplares similares
-
Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond
por: Davidson, David, et al.
Publicado: (2013) -
Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro
por: Amrein, Lilian, et al.
Publicado: (2009) -
Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
por: Lovato, Amanda, et al.
Publicado: (2012) -
Adaptive metabolic rewiring to chronic SFK inhibition
por: Pinedo-Carpio, Edgar, et al.
Publicado: (2016) -
Bruton’s tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes
por: Sharif-Askari, Bahram, et al.
Publicado: (2019)